Summary. The (Edlow, Köhler & Robinson, 1972) . Tissues were homogenized in 9 vols of 0-167 M-potassium chloride for 3 min in an Omni-Mixer (Ivan Sorvall, Inc., Newtown, Connecticut), and the enzyme activity in the homogenates was assayed.
Summary. The activity of monoamine oxidase (MAO), an enzyme which metabolizes catecholamines and indoleamines, was determined in rat placenta at various stages of gestation, in human term placenta, and in choriocarcinoma grown in culture. From Day 15 to Day 20 of gestation the specific activity (units/mg protein) of MAO in rat placenta increased at least 3-fold; from Day 20 to the time of parturition, it decreased about 50 %. The specific activity of MAO in human placenta at term was about 8 times higher than that of rat placenta at term. No MAO activity was found in choriocarcinoma grown in culture.
The present report is the second in a series of investigations on placental enzymes involved in the metabolism of biogenic amines. Previously, we studied the activity of catechol-O-methyltransferase (COMT, E.C. 2.1.1.6) in rat placenta at various stages of gestation, in human term placenta, and in choriocarcinoma grown in culture (Chen, Klein & Robinson, 1974) . In the present study, we have examined the activity of monoamine oxidase (MAO, E.C. 1.4.3.4) because of the role it plays in the oxidative deamination of biologically active monoamines, such as catecholamines and indoleamines (for review see Costa & Sandier, 1972) , which may be important in the physiology of the placenta. It is known that alpha-adrenergic stimulating catecholamines contract and beta-adrenergic stimulating drugs relax pregnant myometrium (for review see Marshall, 1973 (Edlow, Köhler & Robinson, 1972) . Tissues were homogenized in 9 vols of 0-167 M-potassium chloride for 3 min in an Omni-Mixer (Ivan Sorvall, Inc., Newtown, Connecticut) , and the enzyme activity in the homogenates was assayed.
The assay for MAO was a modification of the method of Wurtman & Axelrod (1964) . In a total volume of 500 pi, the incubation mixture contained 250 mM-potassium phosphate buffer, pH 7-4; 0-5 mM-[2-1+C]tryptamine bisuccinate, 0-0325 pCi; and 100 pi enzyme preparation. At the end of incubation at 37°C for 20 min, a 0-2 ml volume of 2 n-HCI was added to stop the reaction. Toluene (1 ml) was then added for extraction of the product. After centrifugation, 0-5 ml toluene extract was added to 10 ml scintillation fluid and the radioactivity was determined. The enzyme activities were expressed in units (nmol product/hour) per g wet wt, per mg protein, per placenta, or per rat, as indicated after correction for 83 % recovery. Protein was determined by the method of Lowry, Rosebrough, Farr & Randall (1951) .
The products in the toluene extract were identified by thin-layer chromatography on precoated silica gel plates (E.M. Laboratories, Inc., Elmsford, New York) with chloroform-methanol (93:7 v/v) and benzene-acetone (90:10 v/v) as the solvent systems (Kaldewey, 1969 The change in COMT activity (Chen et al, 1974) during this period differs from that seen with MAO. Whereas both increase on a per-rat basis, the increase in COMT is 3^-fold and the increase in MAO is 6-fold. When expressed on a per-mg-protein basis, the activity of COMT first decreases about 30% at Day 17 and then returns to values which are slightly higher than the Day-14 values. Thus, in contrast to the 3-fold increase in MAO specific activity, only minor alterations in COMT are evident. After reaching the maximal specific activity around Day 20, rat placental MAO activity decreased to almost half the maximal value at the time of parturition 1-2 days later. This 40-50% decrease in MAO specific activity is noteworthy because no similar change in COMT specific activity (Chen et al, 1974) , placental protein, or mass (unpublished data) occurs during the last 2 days of gestation. A specific regulatory system may exist to control rat placental MAO. This would not be unique because hormonal regulation of MAO activity in several rat organs has been reported (Holtzbauer & Youdim, 1973) . Koren, Pfeifer & Sulman (1965) reported a gradual increase of serotonin and a gradual decrease of MAO in human placenta during pregnancy. They postulated that the accumulation of serotonin toward the end of normal pregnancy might trigger the initiation of delivery. In our study with pregnant rats, we also found a decrease in MAO activity late in pregnancy. Although the time course of this decrease in placental MAO was different in rats and women, the end result was the same, i.e. a decreased ability to degrade biogenic amines via this route. In the rat the capacity for degradation of catecholamines via COMT does not appear to decrease in late pregnancy. Rather, the specific activity of this enzyme remains relatively constant and the total amount actually increases because of the increase in placental mass (Chen et al, 1974) .
It has been reported that the placentae of toxaemic patients have lower MAO activities and higher catecholamine levels than normal placentae (de Maria & See, 1966) . It was suggested that the vasospasm in pre-eclampsia might be due to the presence of such amines. In view of this, placental MAO and COMT could be of importance in the protection of maternal and fetal organs against the noxious effect of pressor amines.
Two types of MAO appear to be present in mammalian tissues (Johnston, 1968; Neff, Yang & Goridis, 1973) . In our study, we used tryptamine, a common substrate for type A and type enzymes. It is not known which type of MAO is present in placenta. Future study of this question will give a better understanding of the actual function of placental MAO.
